828 related articles for article (PubMed ID: 20151785)
21. Long-term effects of botulinum toxin type A (Botox) on facial lines: a comparison in identical twins.
Binder WJ
Arch Facial Plast Surg; 2006; 8(6):426-31. PubMed ID: 17116793
[TBL] [Abstract][Full Text] [Related]
22. Botulinum A toxin for glabellar wrinkles. Dose and response.
Hankins CL; Strimling R; Rogers GS
Dermatol Surg; 1998 Nov; 24(11):1181-3. PubMed ID: 9834736
[TBL] [Abstract][Full Text] [Related]
23. Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines.
Carruthers A; Carruthers J; Flynn TC; Leong MS
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S60-8. PubMed ID: 17241416
[TBL] [Abstract][Full Text] [Related]
24. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial.
Zimbler MS; Holds JB; Kokoska MS; Glaser DA; Prendiville S; Hollenbeak CS; Thomas JR
Arch Facial Plast Surg; 2001; 3(3):165-9. PubMed ID: 11497500
[TBL] [Abstract][Full Text] [Related]
25. Botox in men.
Flynn TC
Dermatol Ther; 2007; 20(6):407-13. PubMed ID: 18093014
[TBL] [Abstract][Full Text] [Related]
26. Evolution of Facial Aesthetic Treatment Over Five or More Years: A Retrospective Cross-sectional Analysis of Continuous OnabotulinumtoxinA Treatment.
Carruthers A; Sadick N; Brandt F; Trindade de Almeida AR; Fagien S; Goodman GJ; Raspaldo H; Smith K; Darmody S; Gallagher CJ; Street J; Romagnano L
Dermatol Surg; 2015 Jun; 41(6):693-701. PubMed ID: 25973559
[TBL] [Abstract][Full Text] [Related]
27. Dermal and epidermal remodeling using botulinum toxin type A for facial, non reducible, hyperkinetic lines: two case studies.
Bowler PJ
J Cosmet Dermatol; 2008 Sep; 7(3):241-4. PubMed ID: 18789065
[TBL] [Abstract][Full Text] [Related]
28. The use of Botulinum toxin-a injection for facial wrinkles: a histological and immunohistochemical evaluation.
El-Domyati M; Attia SK; El-Sawy AE; Moftah NH; Nasif GA; Medhat W; Marwan B
J Cosmet Dermatol; 2015 Jun; 14(2):140-4. PubMed ID: 25916463
[TBL] [Abstract][Full Text] [Related]
29. Botulinum toxins for facial wrinkles: beyond glabellar lines.
Dayan SH; Maas CS
Facial Plast Surg Clin North Am; 2007 Feb; 15(1):41-9, vi. PubMed ID: 17317554
[TBL] [Abstract][Full Text] [Related]
30. Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study.
Alimohammadi M; Andersson M; Punga AR
Acta Derm Venereol; 2014 Jan; 94(1):32-7. PubMed ID: 23975053
[TBL] [Abstract][Full Text] [Related]
31. Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study.
Prager W; Wissmüller E; Kollhorst B; Williams S; Zschocke I
Dermatol Surg; 2010 Dec; 36 Suppl 4():2155-60. PubMed ID: 21134046
[TBL] [Abstract][Full Text] [Related]
32. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines.
Carruthers J; Rivkin A; Donofrio L; Bertucci V; Somogyi C; Lei X; Davis PG; Campo A; Beddingfield FC
Dermatol Surg; 2015 Jun; 41(6):702-11. PubMed ID: 25993609
[TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
Alster TS; Lupton JR
Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
[TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin A treatment of perioral rhytides.
Semchyshyn N; Sengelmann RD
Dermatol Surg; 2003 May; 29(5):490-5; discussion 495. PubMed ID: 12752516
[TBL] [Abstract][Full Text] [Related]
35. A case of dysphagia following botulinum toxin injection for neck rejuvenation.
Phothong W; Wanitphakdeedecha R; Keskool P; Manuskiatti W
J Cosmet Dermatol; 2017 Mar; 16(1):15-17. PubMed ID: 27637174
[TBL] [Abstract][Full Text] [Related]
36. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.
Prager W; Rappl T
J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049
[TBL] [Abstract][Full Text] [Related]
37. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
Carruthers A; Carruthers J; Cohen J
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S97-104. PubMed ID: 17241422
[TBL] [Abstract][Full Text] [Related]
38. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
Carruthers JA; Lowe NJ; Menter MA; Gibson J; Nordquist M; Mordaunt J; Walker P; Eadie N;
J Am Acad Dermatol; 2002 Jun; 46(6):840-9. PubMed ID: 12063480
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin type B: pH change reduces injection pain, retains efficacy.
Lowe PL; Lowe NJ
Dermatol Surg; 2014 Dec; 40(12):1328-33. PubMed ID: 25350125
[TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction.
Sepehr A; Chauhan N; Alexander AJ; Adamson PA
Aesthetic Plast Surg; 2010 Oct; 34(5):583-6. PubMed ID: 20383497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
